Viridian Therapeutics Net Loss History
| VRDN Stock | USD 26.98 -0.86 -3.09% |
Net Loss | First Reported 2010-12-31 | Previous Quarter -4.04 | Current Value -4.24 | Quarterly Volatility 15.27037487 |
Macro event markers
Viridian Therapeutics's Net Loss is influenced by both company-specific factors and broader sector dynamics.
Latest Viridian Therapeutics' Net Loss Growth Pattern
Viridian Therapeutics's Net Loss trajectory spans 14 fiscal years in the chart below. The latest annual change of 4.72% continues a growing multi-year pattern. Flat stretches in Viridian Therapeutics' Net Loss may reflect operational stability or a pause between growth phases.
| Net Loss | 10 Years Trend |
|
Net Income Per Share |
| Timeline |
Net Loss Trend Statistics
| Arithmetic Mean | -19.73 | |
| Coefficient Of Variation | -77.39 | |
| Mean Deviation | 12.20 | |
| Median | -17.57 | |
| Standard Deviation | 15.27 | |
| Sample Variance | 233.18 | |
| Range | 48.4871 | |
| R-Value | 0.79 | |
| Mean Square Error | 95.38 | |
| R-Squared | 0.62 | |
| Significance | 0.0002 | |
| Slope | 2.37 | |
| Total Sum of Squares | 3,731 |
Viridian Therapeutics Net Loss History
| 2026 | -4.24 | ||
| 2025 | -4.04 | ||
| 2024 | -3.98 | ||
| 2023 | -5.31 | ||
| 2022 | -4.05 | ||
| 2021 | -6.66 | ||
| 2020 | -31.13 | ||
| 2019 | -20.04 | ||
| 2018 | -16.57 | ||
| 2017 | -20.66 | ||
| 2016 | -17.57 | ||
| 2015 | -21.0 | ||
| 2014 | -52.46 | ||
| 2013 | -11.48 |
Methodology, Assumptions & Data Sources
This chart follows Viridian Therapeutics's Net Loss across recent years. Year-over-year changes are the easiest way to spot turning points.
For Viridian Therapeutics, this section uses periodic company reporting and market reference feeds with Macroaxis normalization rules applied to keep cross-asset comparisons consistent. Sell-side coverage, where present, supplements the data shown. Intraday timing differences may exist. This section presents reference data and historical patterns only and does not constitute an investment recommendation or advice.